Proteorex Therapeutics aims to discover therapeutics for diseases using a small-molecule drug discovery platform that integrates a synthesis design strategy, computational modeling, and patient-derived cell-based screening.

PharmCADD develops Pharmulator, a computer-aided drug discovery and development platform that utilizes computational science methodologies, advanced machine learning technologies, and molecular dynamics.

Cloud Pharmaceuticals, formerly TeraDiscoveries, is a leader in the computational design of new drugs and subsequent rapid, information-driven drug development. The company accelerates the drug discovery and design process in a way that delivers tangible results and true value for partners.

BioSolveIT visualizes drug discovery. Its software enables every chemist to advance their research. Perceptive visualization helps the users to understand computational results at a glance.

Modulus Discovery is a preclinical-stage technology-driven drug discovery company dedicated to accelerating the discovery of new medicines for patients and their families through the synthesis of computational intelligence, biological inspiration, and global integration. The company is focused on the rapid design and generation of small molecule clinical candidates for a range of high-value disease targets through the use of its computational drug discovery expertise and biology insights.

PharmEnable is a drug discovery company that uses a combination of medicinal chemistry and AI computational approaches to design small molecule drugs.